FDA approves pill for aggressive breast cancer that's spread
U.S. regulators on Friday approved a new drug for an aggressive type of breast cancer that’s spread in the body — including into the brain, where it’s especially tough to treat.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
